Physician profile
John S Suen
NPI 1710987292
$37,532.86
in general payments reported to CMS, 2019-2025
57 companies · $11K in 2025
The $11K reported for 2025 was more than what 99% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,371 · 2020: $1,974 · 2021: $2,559 · 2022: $4,155 · 2023: $4,524 · 2024: $9,060 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14K · Education: $4,626 · Consulting Fee: $3,510 · Travel and Lodging: $2,758.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,579.00 |
| Education | $4,625.89 |
| Consulting Fee | $3,509.82 |
| Travel and Lodging | $2,758.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $5,872.85 | 2023-2024 | Monarch |
| Intuitive Surgical, INC. | $5,141.06 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $3,292.91 | 2019-2025 | Fasenra, Airsupra, Tezspire |
| Glaxosmithkline, LLC. | $2,183.57 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $2,096.27 | 2019-2025 | Ofev, Stiolto Respimat, Jascayd |
| Harmony Biosciences LLC | $1,903.47 | 2020-2025 | Wakix |
| Ethicon INC. | $1,866.26 | 2019-2025 | Monarch Platform |
| Pinnacle Biologics, INC | $1,684.70 | 2019-2023 | Photofrin |
| United Therapeutics Corporation | $1,438.66 | 2021-2025 | Tyvaso, Tyvaso, Orenitram |
| Actelion Pharmaceuticals US, INC. | $1,218.53 | 2019-2025 | Opsumit, Uptravi, Opsynvi |
| Takeda Pharmaceuticals U.S.A., INC. | $1,195.89 | 2020-2025 | Glassia, Hyqvia |
| Jazz Pharmaceuticals INC. | $960.77 | 2019-2025 | Xywav |
| Pulmonx Corporation | $911.56 | 2020-2025 | Chartis Catheter, Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console |
| Insmed, INC. | $798.39 | 2020-2025 | Arikayce, Brinsupri |
| Grifols USA, LLC | $687.74 | 2019-2025 | Prolastin-C Liquid |
Show all 57 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $638.15 | 2021-2025 | Dupixent |
| Mylan Specialty L.P. | $606.17 | 2019-2024 | Yupelri, Yupelri |
| Inspire Medical Systems, INC. | $562.68 | 2023-2025 | Inspire |
| Philips North America LLC | $405.64 | 2019-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Merck Sharp & Dohme LLC | $377.68 | 2023-2025 | Keytruda, Winrevair |
| Bayer Healthcare Pharmaceuticals INC. | $367.85 | 2019-2023 | |
| Genentech USA, INC. | $277.56 | 2019-2020 | |
| Inogen, INC. | $256.63 | 2022-2025 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Axsome Therapeutics, INC. | $220.71 | 2023-2025 | Sunosi |
| Veran Medical Technologies, INC. | $214.31 | 2020 | |
| Electromed, INC. | $206.12 | 2019-2024 | Smartvest |
| Paratek Pharmaceuticals, INC. | $191.86 | 2022-2025 | Nuzyra |
| Boston Scientific Corporation | $181.54 | 2021-2024 | Rezum Generator, Acquire |
| Amgen INC. | $125.72 | 2022-2025 | |
| Baxter Healthcare | $116.13 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Shire North American Group INC | $103.22 | 2019 | |
| Verona Pharma, INC. | $99.18 | 2025 | Ohtuvayre |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $95.66 | 2023 | Lifevest |
| Resmed Corp | $92.75 | 2023-2025 | |
| Circassia INC. | $91.54 | 2019-2020 | |
| Vifor Pharma, INC. | $90.00 | 2024-2025 | Zemaira |
| Medline Industries LP | $82.66 | 2019 | |
| Genzyme Corporation | $78.79 | 2024-2025 | |
| Melinta Therapeutics, LLC | $71.95 | 2021 | |
| Advanced Respiratory, INC | $71.52 | 2019-2020 | |
| Pfizer INC. | $66.86 | 2022-2023 | |
| Eisai INC. | $62.86 | 2020-2021 | |
| Mallinckrodt Hospital Products INC. | $61.26 | 2022-2025 | Acthar |
| Olympus America INC. | $58.07 | 2024 | Spiration Valve System |
| Fisher & Paykel Healthcare INC | $49.13 | 2022 | |
| Lilly USA, LLC | $47.51 | 2022-2025 | Zepbound |
| Olympus Corporation of The Americas | $43.86 | 2022 | |
| Avadel Cns Pharmaceuticals, LLC | $38.69 | 2025 | Lumryz |
| Vapotherm INC | $35.84 | 2019-2022 | |
| Caris Mpi, INC. | $34.24 | 2025 | Mi Cancer Seek |
| Teva Pharmaceuticals USA, INC. | $29.30 | 2019-2022 | |
| Idorsia Pharmaceuticals US INC | $24.22 | 2022 | |
| Tactile Systems Technology INC | $22.73 | 2023 | Entre Plus, Flexitouch Plus |
| Arbor Pharmaceuticals, INC. | $22.53 | 2019 | |
| Nabriva Therapeutics, Plc | $21.71 | 2020 | |
| Gilead Sciences, INC. | $19.57 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $15.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Suen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.